Optimizing Treatment Regimens, Switching and Sequencing in Multiple Sclerosis: Leveraging Data to Make Informed Decisions 

A continuing medical education activity sponsored by NAMCP and AAMCN

This webinar series will provide critical updates on the advances in immunotherapies, including how
to translate the most recent data into clinical and administrative practice.

These are archives of live webinars held between December 9 to December 18, 2019.
If you participated in any of the live webinars, you are not eligible to claim credit from the archive of that webinar.

By clicking on each of the titles, you will be able to participate in each part.
It is not required that you participate in all 3 or in order.

Each session has its own specific valid dates

This series is supported by educational grants from
 Biogen and Genzyme Corporation

 Audience: This activity is intended for healthcare professionals practicing in managed care environments.


Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

Multiple Sclerosis (MS) is a chronic progressive disease. It is the most common neurological cause of disability among young adults, with a prevalence of approximately 400,000 cases throughout the US, and every week around 200 people are diagnosed with the disease. Although there is still no cure for MS, many advances in MS treatment have arrived in recent years, allowing patients to manage these symptoms and improve their quality of life. While the explosion of these therapies have shown the ability to improve outcomes and quality of life in patient's MS, it makes staying current with best practices a challenge. This webinar series will allow attendees to be aware of the current treatment landscape as well as the cost implications to best develop a benefits design strategy and treatment plans that can minimize the economic burden and optimize care.

A Deeper Look into the Latest Data in the Treatment of Multiple Sclerosis: Leveraging Recent Evidence to Make Informed Decisions

  1. Examine the impact of multiple sclerosis (MS) on a patientís quality of life and the burden to the healthcare system
  2. Identify key pathogenic mechanisms identified in multiple sclerosis (MS) and implications for targeted therapies
  3. Analyze updated clinical data on the efficacy, safety, and dosing/administration of current and emerging therapies and their effect on staging and sequencing
  4. Explore recently updated evidence-based data for the rationale of sequencing, switching, and/or escalating MS therapeutics
  5. Implement knowledge about MS therapies and aspects of a patient's presentation to make an informed decision when switching MS therapies
       Physician, Nursing and CMCN credits valid to January 1, 2022

Improving Quality of Life and Patient Adherence in Multiple Sclerosis: New Insights on Induction, Escalation, Oral Agents, and Monitoring

  1. Assess challenges to patient adherence, dosing and quality of life in MS management
  2. Discuss the evolving role on oral agents in the treatment of multiple sclerosis (MS) and their effect on patient adherence
  3. Apply the latest updates on the use of MRI and clinical findings that may prompt consideration of switching therapy for MS
  4. Examine strategies to monitor and manage adverse events associated with current and emerging disease modifying therapies in MS in order to improve patient adherence and quality of life
  5. Analyze care pathways and their application to manage and improve economic outcomes in MSxplore challenges to patient adherence and quality of life in PIDD and discuss strategies to overcome those challenges
       Physician, Nursing and CMCN credits valid to January 1, 2022

Comparative Effectiveness and Payer-Provider Coordination in Multiple Sclerosis: What Does Managed Care Need to Know?

  1. Review the available health economics & outcomes research (HEOR) and real world phase IV data of MS treatments
  2. Discuss recent insights into cost offsets associated with new and emerging MS therapies
  3. Integrate utilization management and benefit design strategies for MS therapies to enhance clinical and economic outcomes for patients with MS
  4. Identify co-productive payer-provider strategies to ensure appropriate and timely access to disease-modifying therapies for MS
  5. Identify practices that managed care professionals can take to help improve outcomes, mitigate disease progression and ensure appropriate and timely access to disease-modifying therapies for MS
      Physician, Nursing and CMCN credits valid to January 1, 2022